QA: Affymax INC in us_pharma/2012

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001158223_2013_Affymax_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Missing logo subcommand.report {}
info NetIncome node detected by tax heuristic input.sec.calculation_linkbase.edgar_model_mapping {'net_inc_node': 'NetIncomeLossAvailableToCommonStockholdersBasic'}

Graph

Absolute values for 0001158223, Affymax INC

  xvar xval
0 AssetsCurrent 102,510,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 2,981,000
3 remainder_Assets 12,726,000
4 LiabilitiesCurrent 99,075,000
5 LiabilitiesNoncurrent 799,000
6 remainder_Liabilities 10,062,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 89,714,000
9 ResearchAndDevelopmentExpense 51,738,000
10 remainder_Expenses 46,373,000
11 remainder_Revenues 94,370,000
12 remainder_NetIncome 43,000
13 remainder_ComprehensiveNetIncome -20,000
  yvar yval
0 Assets 118,217,000
1 Liabilities 109,936,000
2 Expenses 187,825,000
3 Revenues 94,370,000
4 StockholdersEquity 8,281,000
5 NetIncome -93,412,000
6 ComprehensiveNetIncome -93,422,000
7 BaseVar 255,205,500
8 EconomicCapitalRatiobeforeLimitedLiability -0.661
9 EconomicCapitalRatio 1.36

Edgar->Model Mapping

Feature Distribution

Change over Time